Healthcare

Could Early Warnings Spell Trouble for Well Health?
April 02, 2025 04:11 AM AEDT| By Team Kalkine MediaHighlights,Well Health Technologies Corp issues an early warning release.,Institutional communication reveals significant internal updates.,The news focuses on operational changes within,healthcare technology.,Well Health Technologies Corp (TSXV:WELL...

Could Healwell AI's Earnings Conceal a Hidden Crisis?
April 02, 2025 03:58 AM AEDT| By Team Kalkine MediaHighlights,Healwell AI posts earnings that surpass previous performance.,The healthcare firm experiences robust revenue growth amid market challenges.,Operational efficiency and institutional involvement define recent sessions.,The,healthcare industr...

Is MediPharm Labs Gaining Momentum In The Pharmaceutical Industry?
March 27, 2025 06:25 AM AEDT| By Team Kalkine MediaIs MediPharm Labs Gaining Momentum in the Pharmaceutical Industry?

Is Medicenna Therapeutics Facing an Imminent Downturn?
March 27, 2025 06:17 AM AEDT| By Team Kalkine MediaHighlights:,Secured significant market updates and achieved recent regulatory milestones.,Advanced clinical data supports its development pipeline and research focus.,Institutional interest remains strong amid evolving market dynamics.,Medicenna Ther...

Could Knight Therapeutics Be Heading for a Major Downturn?
March 27, 2025 06:11 AM AEDT| By Team Kalkine MediaHighlights,Shifts in institutional investment patterns observed,Expanded specialty pharmaceutical product offerings enhance portfolio,Regulatory pressures and operational adjustments shape current direction,Knight Therapeutics (TSX:KNT) operates with...

How Is Extendicare Addressing Workforce Challenges In Senior Care?
March 27, 2025 06:01 AM AEDT| By Team Kalkine MediaHow Is Extendicare Addressing Workforce Challenges in Senior Care?

Rubicon Organics' Stock Performance and Market Position
March 24, 2025 12:34 PM AEDT| By Team Kalkine MediaHighlights:,Share value has seen a significant upward movement in recent weeks.,Revenue expansion has surpassed broader industry expectations.,Price-to-sales ratio has adjusted in alignment with industry benchmarks.,Rubicon Organics (TSXV:ROMJ) opera...

Growth in Revenue and Market Performance for Dentalcorp Holdings
March 24, 2025 12:33 PM AEDT| By Team Kalkine MediaHighlights:,Revenue saw an increase, reflecting positive business momentum.,Net loss decreased, indicating improvements in financial performance.,Market performance showed an upward trend over the past week.,Operating within the,Healthcare Stocks,sec...

Is Auxly Cannabis Group (TSE:XLY) Overleveraged?
March 24, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights:,Auxly Cannabis Group has significantly reduced its financial obligations over the past year.,The company's balance sheet reflects a shift towards improved debt management and liquidity.,Strong conversion of operating income into cash flow...

Why Did Savaria's Executive Chairman Make A Recent Share Purchase?
March 22, 2025 09:50 AM AEDT| By Team Kalkine MediaWhy Did Savaria's Executive Chairman Make a Recent Share Purchase?

Is Dentalcorp's Revenue Growth Slowing Down Already?
March 22, 2025 08:59 AM AEDT| By Team Kalkine MediaHighlights,Quarterly revenue increased moderately compared to previous period.,Adjusted earnings showed steady improvement year-over-year.,Same Practice Revenue Growth was positive but remained modest.,Dentalcorp Holdings Inc. (TSX:DNTL) operates wit...

Can Helix BioPharma Sustain Operations Without New Funding?
March 22, 2025 05:29 AM AEDT| By Team Kalkine MediaCan Helix BioPharma Sustain Operations Without New Funding?

Are Strong Earnings Hiding Deeper Concerns in Pharma?
March 22, 2025 04:34 AM AEDT| By Team Kalkine MediaHighlights,• Revenue improved from previous fiscal performance,• Net income shifted from negative to positive territory,• Share value experienced a modest recent rise,Within Canada's pharmaceuticals sector, Knight Therapeutics (TSX:GUD) has delivered...

Could Charlotte's Web Holdings Be Heading for Trouble?
March 22, 2025 04:32 AM AEDT| By Team Kalkine MediaHighlights,Revenue experienced a significant decline.,Net loss expanded markedly compared to last year.,Share performance showed a modest gain recently.,Charlotte's Web Holdings operates within the Canadian Pharmaceuticals arena and has recently rele...

Is Crescita Therapeutics Shifting Its Fiscal Trajectory in the Biopharma Sector?
March 21, 2025 04:35 AM AEDT| By Team Kalkine MediaHighlights,A marked increase in revenue was observed in the recent fiscal period.,The company experienced a significant expansion in its net loss compared to the prior year.,Recent trading sessions registered a modest rise in share price over the pas...

Is Crescita Therapeutics Shifting Its Fiscal Trajectory in the Biopharma Sector?
March 21, 2025 04:34 AM AEDT| By Team Kalkine MediaHighlights,A marked increase in revenue was observed in the recent fiscal period.,The company experienced a significant expansion in its net loss compared to the prior year.,Recent trading sessions registered a modest rise in share price over the pas...

Can Cipher Pharmaceuticals Sustain Its Revenue Growth?
March 21, 2025 04:33 AM AEDT| By Team Kalkine MediaHighlights:,Revenue climbed significantly, reaching US$33.4m with an increase of 58%.,Net income decreased by 43% amid elevated operational expenses.,Forward revenue growth rate is set to exceed that of the Canadian pharmaceuticals sector.,Cipher Pha...

Is Healwell AI Nearing A Major Breakthrough In Healthcare AI?
March 21, 2025 04:02 AM AEDT| By Team Kalkine MediaIs Healwell AI Nearing a Major Breakthrough in Healthcare AI?

Will Surging Revenue Outweigh Widening Losses in Canadian Pharma?
March 20, 2025 01:31 AM AEDT| By Team Kalkine MediaHighlights,Elevated revenue compared to previous period,Net results reveal deeper deficit,Share value drops in recent trading,Operating in the Canadian pharmaceuticals domain, High Tide Inc. (TSXV:HITI) recently disclosed details about its first quar...

Is Knight Therapeutics Redefining Canadian Pharma Trends?
March 19, 2025 10:31 AM AEDT| By Team Kalkine MediaHighlights:,Knight Therapeutics (TSX:GUD) exhibits a price-to-sales ratio that stands above many of its industry peers.,The company has achieved notable revenue growth compared to a substantial portion of the Canadian pharmaceutical sector.,Market pa...
Canadian AI All-Stars: Unveiling the Top Stocks for 2025